13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$504.61B
+1.2% on the quarter before
Positions
1,982
196 new · 192 sold out
Top 10
18.1%
of the value
Est. gain
+$12.07B
on stocks held all quarter
Est. return
+2.6%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$2.81BNew · 0.0% → 0.6%+7,906,629 shares
- Amazon~$1.38BAdded · 1.1% → 1.6%+13,355,679 shares
- Alphabet~$1.32BAdded · 1.3% → 1.7%+12,762,623 shares
- AMD~$1.10BAdded · 0.1% → 0.4%+11,195,952 shares
- Meta~$1.02BAdded · 0.4% → 1.0%+4,833,063 shares
- Nextera Energy Inc~$1.00BAdded · 0.3% → 0.5%+12,976,594 shares
- Diamondback Energy Inc~$912.2MAdded · 0.1% → 0.3%+6,748,670 shares
- Pfizer Inc~$799.8MAdded · 2.0% → 1.8%+19,602,359 shares
- Merck & Co Inc~$696.5MAdded · 1.4% → 1.4%+6,546,946 shares
- Microsoft~$642.9MAdded · 3.1% → 3.8%+2,230,113 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$2.61BSold out · 0.5% → 0.0%−7,991,836 shares
- Schwab Charles Corp~$2.58BCut · 1.3% → 0.3%−49,196,101 shares
- Baxter Intl Inc~$1.44BCut · 0.4% → 0.0%−35,544,843 shares
- Tjx Cos Inc New~$1.09BCut · 1.5% → 1.2%−13,942,173 shares
- Fidelity Natl Information Sv~$850.5MCut · 0.4% → 0.1%−15,653,458 shares
- Lowes Cos Inc~$738.4MCut · 0.2% → 0.0%−3,692,343 shares
- Seagen Inc~$617.9MCut · 0.3% → 0.3%−3,051,829 shares
- Ubs Group Ag~$601.0MCut · 0.2% → 0.1%−28,464,808 shares
- Mastercard~$583.1MCut · 1.0% → 1.0%−1,604,465 shares
- Boston Scientific Corp~$562.1MCut · 0.5% → 0.5%−11,234,685 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +3.5% · price +20.2% | 3.8% | $19.04B | +$3.09B | ||||||||
| Unitedhealth Group IncCOM · shares +0.6% · price −10.9% | 2.3% | $11.38B | −$1.38B | ||||||||
| AppleCOM · shares −5.4% · price +26.9% | 1.9% | $9.47B | +$2.01B | ||||||||
| Pfizer IncCOM · shares +9.8% · price −20.4% | 1.8% | $8.93B | −$2.08B | ||||||||
| AlphabetCAP STK CL A · shares +18% · price +17.6% | 1.7% | $8.74B | +$1.11B | ||||||||
| AmazonCOM · shares +21% · price +23.0% | 1.6% | $7.83B | +$1.21B | ||||||||
| Merck & Co IncCOM · shares +11% · price −4.1% | 1.4% | $7.29B | −$282.8M | ||||||||
| Eli LillyCOM · shares +1.6% · price −6.1% | 1.4% | $6.98B | −$448.6M | ||||||||
| Tjx Cos Inc NewCOM · shares −15% · price −1.6% | 1.2% | $6.13B | −$97.0M | ||||||||
| Texas InstrumentsCOM · shares +5.6% · price +12.6% | 1.1% | $5.33B | +$563.6M | ||||||||
| Procter And Gamble CoCOM · shares +1.6% · price −1.9% | 1.00% | $5.02B | −$95.4M | ||||||||
| Danaher CorporationCOM · shares −2.2% · price −5.0% | 0.98% | $4.95B | −$262.9M | ||||||||
| MetaCL A · shares +26% · price +76.1% | 0.98% | $4.93B | +$1.69B | ||||||||
| Visa Inc.COM CL A · shares −6.1% · price +8.5% | 0.96% | $4.86B | +$381.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares −7.1% · price −2.8% | 0.96% | $4.85B | −$141.1M | ||||||||
| MastercardCL A · shares −11% · price +4.5% | 0.96% | $4.85B | +$209.1M | ||||||||
| Home Depot IncCOM · shares +6.3% · price −6.6% | 0.92% | $4.64B | −$306.8M | ||||||||
| Stryker CorporationCOM · shares −5.1% · price +16.8% | 0.91% | $4.61B | +$662.1M | ||||||||
| ConocophillipsCOM · shares +2.6% · price −15.9% | 0.88% | $4.44B | −$819.1M | ||||||||
| Mcdonalds CorpCOM · shares −4.0% · price +6.1% | 0.86% | $4.32B | +$248.5M | ||||||||
| Morgan StanleyCOM NEW · shares +2.0% · price +3.3% | 0.82% | $4.12B | +$127.9M | ||||||||
| Honeywell TechnologiesCOM · shares −1.5% · price −10.8% | 0.81% | $4.06B | −$492.8M | ||||||||
| Raytheon Technologies CorpCOM · shares −3.2% · price −3.0% | 0.80% | $4.01B | −$122.5M | ||||||||
| Nike IncCL B · shares −1.4% · price +4.8% | 0.78% | $3.95B | +$181.2M | ||||||||
| Johnson & JohnsonCOM · shares −5.5% · price −12.3% | 0.78% | $3.93B | −$549.6M | ||||||||
| Total · 1,982 positions | 100% | $504.61B | +$12.07B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 1,693 stocks held throughout, up $12.07B (+2.6%).
- Microsoft+$3.09B+20%
- Apple+$2.01B+27%
- Meta+$1.69B+76%
- Amazon+$1.21B+23%
- Alphabet+$1.11B+18%
- Johnson & Johnson−$549.6M−12%
- Conocophillips−$819.1M−16%
- Schwab Charles Corp−$946.5M−37%
- Unitedhealth Group Inc−$1.38B−11%
- Pfizer Inc−$2.08B−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |